Adamantem Capital, a specialised Australian private equity firm, agreed to acquire CardioCo, a cardiology services group, from GenesisCare, a provider of integrated cancer care globally and cardiology services in Australia. Financial terms were not disclosed. With Adamantem’s new investment, CardioCo will demerge from the GenesisCare network upon completion of the transaction to become Australia’s standalone cardiology services group. “This divestment is the natural next step for both CardioCo and GenesisCare. It will fuel CardioCo’s next phase of growth and continue the exceptional progress in clinical trials, government partnerships, and pioneering novel therapies. For GenesisCare, we can focus our efforts solely on our integrated oncology program and sharing our best practice and innovation developments across all markets. Adamantem Capital is an excellent partner for doctors, management, and the business, and I wish the new combination every success," Dan Collins, GenesisCare Global CEO and Founder.